Wednesday, November 18, 2026

The Rocky Road from Aggregate to Per Share Value: Anthropic's IPO update

     I valued Anthropic in a post on November 2, 2026, and while estimating a value of $1.475 trillion for the equity in the company, I noted that the share count was a placeholder, while we waited for bankers to make a final judgment on how many shares would be outstanding in the company. I promised that I would return to complete the per share valuation, when the details were made available, and an updated prospectus filed last week filled that gap. The world has not stayed still in the fifteen days since my original valuation, and both company-level and macro developments require an update to my valuation. The prospectus was updated to include third quarter numbers, and the midterm elections have potentially altered the economics of the AI business, as data centers may become more difficult and expensive to build and AI regulations may become more stringent. In this post, I will start with a general discussion of how share count is complicated by the existence of multiple classes of shares and stock-based compensation, and argue that the absence of standardization has made share count the Wild West in investing, with consequences for both intrinsic valuation and pricing. I will then update my valuation of Anthropic and assess the per share value, based on the prospectus that was just filed.

The Elusive Share Count

    When I first started valuing companies,  getting from aggregate value to equity value per share was  a trivial exercise, where you divided the aggregate value by the number of shares outstanding. This was, of course, a period when almost every US company had only one class of shares and stock-based compensation was still in its nascent stages, and lightly used. That is no longer the case, and while tedious, I think that the process of understanding share count has to start with the basics of what goes into that number for publicly traded companies.

  1. Primary share count: The primary share count is obtained by looking at the shares in the company, across all classes of shares. That information is usually embedded in the balance sheet or in the footnotes, but with different numbers usually for authorized, issued and outstanding shares. The authorized share count is the least relevant of the numbers and is just a measure of the total number of shares that the company can issue, with an increase beyond it requiring a fresh authorization. The shares issued are a measure of the shares that the company issued to the market and while shares outstanding match shares issued for most firms, the presence of treasury stock (stock acquired back by a company, but held by the company) can cause outstanding shares to be lower than issued shares. 
  2. Restricted shares: Restricted shares comprised shares that have been issued by the company to its employees, though in rare cases, they can also be issued to the public. The restrictions take two forms. With employee issuances, there can be a vesting requirement, where an employee has to work for a specified period to be able to lay claim to the shares. The other is that even after vesting, these shares sometimes can come with restrictions on liquidity; i.e., the holders of these shares cannot trade the shares easily.
  3. Options: The third claim on equity can come from options granted by the company to employees and sometimes lenders, with the latter manifesting as conversion options in convertible bonds or convertible preferred stock. The former are part of employee compensation and come with specified maturities, and often require vesting, just like restricted stock. The latter are included with bonds, and used to raise money from investors, with the conversion option usually running for life time of the bond, giving holders of the bond the right to swap their bond for shares in the company. Options give you the right to buy shares in the company at a fixed price (the exercise price), and as a consequence, they are different from primary and restricted shares in two ways. The first is that if the company's stock price drops below the exercise price (making it out of the money), it does not make sense to exercise the option, thus keeping it out of the share count. The second is that even when the stock price is higher than the exercise price (making it in-the-money), holders may not exercise the option, because there may be an advantage to holding the option for longer, hoping for a bigger payoff. This creates a time premium in the option, where the option is worth more than what you would get from exercise today. When you use an option pricing model, you are in effect trying to incorporate the current stock price, the exercise price, the likelihood that you will exercise the option and the expectations of future stock prices into a number.

For some older and more mature companies, it is possible that the only shares outstanding are the primary shares, and getting a share count is easy. For most companies, though, and especially young firms that use stock-based compensation heavily (because they don't have the cash to pay employees), restricted shares and options outstanding can make a significant difference. For these companies, there are often two limiting numbers that define the extremes of share count. The first is just the primary share count, which will be the lowest of the share count numbers. The second is the fully diluted share count, where you count not just shares outstanding today, but all shares that could be outstanding if the restricted stock is vested and all options (employee and conversion) get exercised, giving you the highest share count. There is an intermediate solution of partially diluted shares, where rather that count all restricted stock and options, you may count only the vested shares (for restricted shares) and the in-the-money options (for employee options). 

Share Count in Intrinsic Valuation

    Since intrinsic valuation is about estimating how much you value individual shares in a company to make a judgment on whether a stock is under or over valued, the share count clearly matters, since having more shares outstanding will yield a lower value per share. There are three ways in which you will see analysts and investors deal with this overhang:

  • The Bludgeon: In the bludgeon approach, you let simplicity be the driver of your choice and go with either the primary shares or the fully diluted shares, with the values per share you get reflecting the outer ranges of your per share value estimates. The primary shares approach, with the lowest share count, will yield the highest value per share, and in companies with restricted stocks and options outstanding, that value per share will be too high. 

Primary share value per share = Aggregate Equity Value/ Primary shares outstanding

The fully diluted shares approach, with the highest share count, will yield the lowest value per share, and many investors prefer it, contending that it is better to be conservative.  

Fully diluted share value per share = Aggregate Equity Value/ Fully diluted shares outstanding

The problem with this approach, though, is that it counts all options, in and out of the money, as part of the share count, and not only assumes immediate exercise, but that the company will not receive the exercise proceeds, leading to an even greater underestimation. It is true that using a partially diluted share count will provide a partial solution, by removing out-of-the-money options but the remaining problems will persist.

  • The Refined Bludgeon: The second approach (called the Treasury stock approach) tries to remedy the failure to include exercise proceeds from option exercise in value per share, by adding those proceeds to the value of equity, and doing so will push your value per share, relative to a fully diluted share value:

Treasury stock value per share = [Aggregate value of equity + Strike Price × Options outstanding]/ Partially diluted shares

Here, you use only the options that are in the money, because out-of-the-money will give you a value boost by bringing an exercise price higher than the stock price that is fantasy. The problem with this approach is that it ignores the time premium on options, effectively undervaluing those options, and will result in a value per share that is too high.

  • The Scalpel: As I noted earlier, options are different from any other share category, because they may or may not be exercised, depending on the stock price, and there is uncertainty about when they will be exercised, even when in-the-money. Consequently, the right approach in valuation is to estimate the value of options, using an option pricing model) and then subtract that value from aggregate equity value to arrive at a equity value for just shares outstanding (primary and treasury). Dividing that residual value by a share count that includes only primary and restricted shares will come closest to capturing the correct value per share:

Option-adjusted value per share = [Aggregate value of equity − Value of options outstanding]/ (Primary + Restricted Shares issued)

It is true that to value options, you will need information on the exercise price and maturity, but that is required disclosure now at US companies. With this approach, you no longer have to separate in-the-money from out-of-the-money options, since both will have value, and the option pricing model will adjust the value for the exercise price (relative to stock price) and the time left on the option.

The picture below summarizes these contrasting estimates of value per share, using different share counts:


Again, rather than view these as competing estimates, I would suggest viewing the option-adjusted value per share as the number closest to the truth, and the rest as approximations, with the primary and the fully diluted estimates not even in the running.

    Having different classes of shares with divergent voting rights and claims to cashflows adds a layer of complexity to this process, since to bring those differences into play, you have to make a judgment on how much voting rights and cash flow claims matter, and incorporate those judgments into values per share that will be different for different share classes, with voting shares valued at a premium relative to non-voting shares.

Anthropic: Intrinsic Value per share

    The Anthropic updated prospectus lays out the gory details, and they are gory, of share count in this company:


As you can see, there are multiple classes of shares and I am not even bringing in the class T shares that the trust holders or the founder share, with 50.01% of the voting rights in perpetuity. There are five details relating to shares outstanding that are worth emphasizing. 

  • The IPO will result in the issuance 801 million additional class A shares that are added to the share count. 
  • There are 1026 million restricted shares, and given that they have a four-year vesting period, none are vested yet. 
  • There are 1,774 million options outstanding, all likely to be deep in-the-money (with a strike price of $2.91, well below the expected offering price of $70-78 per share), with 1,082 million vested already. There are eight years of option life left, indicating that there will be a time premium, albeit a small one.
  • The company has made a commitment to donate shares under a matching plan, once it goes public, with 933.7 millions tagged for the plan
  • The conversion options in the convertible bonds should normally be separated out and treated as options, but if I read the prospectus correctly, it looks like they will be converted shortly after the IPO into shares.
With those caveats in place, the share count ranges from 14,875.18 million shares, if you count only shares outstanding (and don't count the donation shares, the shares on conversion of the convertible bonds, restricted shares or options) to 17,676.18 units, if you have a fully diluted count. You have intermediate solutions, with variants based on whether you include vested units or not), but the value per share will vary widely, depending on the count.

    To arrive at the value per share, I started with a valuation of the aggregate equity in the company, using the storyline I developed more fully in an earlier post, but I made four changes;
  • I updated the base year numbers (for the last twelve months) to include the third quarter (of 2026) data that was provided in the updated prospectus. The effect on overall value is muted, because while there was a slowing down in the annualized revenue run rate in the third quarter, that was already known and incorporated into the earlier story and valuation.
  • I adjusted the cash proceeds down from $100 billion, a rumored value at the time of my original valuation, to about $60 billion, based on an expected offering price of $74 and the disclosed shares that they plan to issue (801 million). That lowers the post-IPO value of equity by the difference of $40 billion.
  • I do not want to overreact to the election results, but I do think it is prudent to assume that building data centers will become more expensive (captured by lowering the sales Anthropic will get per dollar of capital invested in the first five years from $3 to $2.75. This increases expected reinvestment and lowers cash flows).
  • It is unclear whether and how a new Congress will regulate AI, but here again the prudent path seems to be that the drag on margins will get larger, from 5% to 6%, lowering the target margin to 26.5%.
The resulting value for the firm and its equity is below:
Updates in red; Link to spreadsheet

The resulting aggregated equity value is $1,351,556 million, with the drop in estimated value mostly a result of the updated compute costs and regulatory drag. To convert that number into an equity value per share, I use all of the approaches from the last section:



Note that while there is a range of values here, from $76.46 (fully diluted) to $90.86 (primary), the value that I would use is the option adjusted value per share of $76.98. The offer price has not been set, at the time of this post, but the real comparison should be to the price that Anthropic will open trading at tomorrow. (Right after this post was written, the news story reported that the offer price has been set at $83/share).

     Note that I have studiously avoided trying to estimate the value per share, by share class, in spite of the fact that the shares differ in voting rights. That is because of the company's uncommon voting structure, where the voting rights reside in a single share owned by the founders. The closest parallel I can think of for this structure are the golden shares that governments put into government-owned utilities and companies that were privatized in the 1980s and 1990s. That golden share gives governments veto power over major decisions, but not power over the day-to-day operating choices made by a company. Anthropic's founder share is far more powerful, and I do think that there is a danger in loading up this much power in a single share. I don't want to give governments and regulators ideas, but I can visualize an activist regulator, finding Anthropic at fault for an AI accident, and  using public safety as a rationale for expropriating the founder's share to make the company a government-controlled utility. I am sure that the founders will try to get the courts to step in, claiming (rightly) expropriation, but why tempt fate?

Share Count in Pricing

    You may be uninterested in intrinsic value and focused on pricing Anthropic in the market, but you will still run into share count in multiple places. The first is in the market cap, a number that gets used widely to rank firms and talk about valuations, where using different share count measures can lead to very different market cap estimates. The second is in computing pricing multiples, where market cap becomes an input into estimating enterprise value or is used a stand alone. The third is in computing per share numbers for earnings, revenues or any other metric, since per share requires the use of a share count; the primary earnings per share will be very different from fully diluted earnings per share.

    Almost every financial data news service will report the market capitalization as part of the core descriptives for a company, and companies are often ranked based on market capitalization. Given that reality, it is surprising how much variability there is across services on reported market capitalizations for some of the highest profile companies in the market:

Market capitalizations, end of trading day on 11/18/26

The differences are small in this group, but as you look at younger and high-growth firms, especially with large stock-based compensation overhangs, the differences will widen. If you are comparing across companies, you may believe that using the same per share metric (primary, diluted, partially diluted etc.) for all the companies in your group will yield comparable numbers but that is not true, since there can be wide variations in the use of restricted stock and options across companies. Since these market capitalizations are fed into enterprise value and earnings per share calculations, it should come as no surprise that EV multiples and PE ratios will vary across services, for the same company at the same point int time.

    So what is the correct market capitalization for a company? I can offer an answer, but I can also guarantee you that there is no single service that I know of that following this practice. It is to take the option-adjusted approach in valuation and flip it around to get a market capitalization:

Option-adjusted Market Capitalization = (Share price × Number of primary and restricted shares outstanding) + Value of employee options and conversion options, at current stock price

This will yield values that allow you to compare companies with very different option counts, as well as differences in how in-the-money the options are at each company.

    Once Anthropic goes public tomorrow and has a listed market price, you should expect to see these share count inconsistencies come into play, as services will report different market capitalizations for Anthropic, using the share price, and different share counts. As with intrinsic valuation, the purely primary share based estimate and the fully diluted estimates will both be off for the company, with the former too high a number and the latter too low a number. You could settle the difference by valuing the options (my spreadsheet has a worksheet that will do that for you), and coming up with the correct value.

Conclusion

    Most investors and analysts pay little heed to share count, and how it is computed, and with mature firms, that oversight may have only minor consequences. As your search leads you to look at firms earlier in the life cycle, I would recommend paying attention to the footnotes, especially related to restricted stock and employee options, and if you have convertibles, to how the conversion option is being accounted for. With Anthropic, it is the accounting for the surge in the value of the conversion option, as its pricing increased in private markets, that led to the $74 billion one-time and non-cash charge to earnings in 2026. I have much to do tomorrow that is not market-related and I will not be watching the Anthropic open, but hopefully, you will and keep me posted!

YouTube Video

Spreadsheets

  1. Updated valuation for Anthropic (November 18, 2026)
Blog Posts on Valuing Anthropic


No comments: